Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 13 Relevant journals, 16 Conferences, 11 Workshops are presently dedicated exclusively to breathing disorder and about 386 articles are being published on Asthma.
Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition are said to be asthmatic. The inside walls of an asthmatic's airways are swollen or inflamed. This swelling or inflammation makes the airways extremely sensitive to irritations and increases your susceptibility to an allergic reaction. As inflammation causes the airways to become narrower, less air can pass through them, both to and from the lungs. Symptoms of the narrowing include wheezing (a hissing sound while breathing), chest tightness, breathing problems, and coughing. Asthmatics usually experience these symptoms most frequently during the night and the early morning. Asthma is thought to be caused by a combination of genetic and environmental factors. Its diagnosis is usually based on the pattern of symptoms, response to therapy over time. It is clinically classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
According to World Health Organization (WHO) estimates 235 million people worldwide suffer from asthma. Asthma is the most common chronic disease among children. Asthma is not just a public health problem for high income countries: it occurs in all countries regardless of level of development. Over 80% of asthma deaths occur in low- and lower-middle income countries. Asthma is under-diagnosed and under-treated, creating a substantial burden to individuals and families and possibly restricting individuals’ activities for a lifetime.
Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm . Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition are said to be asthmatic. The inside walls of an asthmatic's airways are swollen or inflamed. This swelling or inflammation makes the airways extremely sensitive to irritations and increases your susceptibility to an allergic reaction. As inflammation causes the airways to become narrower, less air can pass through them, both to and from the lungs. Symptoms of the narrowing include wheezing (a hissing sound while breathing), chest tightness, breathing problems, and coughing. Asthmatics usually experience these symptoms most frequently during the night and the early morning. Asthma is thought to be caused by a combination of genetic and environmental factors. Its diagnosis is usually based on the pattern of symptoms, response to therapy over time. It is clinically classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic) where atopy refers to a predisposition toward developing type 1 hypersensitivity reactions. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol) and oral corticosteroids. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or leukotriene antagonists may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. The occurrence of asthma has increased significantly since the 1970s. In 2011, 235–300 million people globally have been diagnosed with asthma, and it caused 250,000 deaths. Asthma is an incurable illness. However, with good treatment and management an asthma patient can live a normal and active life. An asthma episode, or an asthma attack, is when symptoms are worse than usual. They can come on suddenly and can be mild, moderate or severe. Asthma affects people of all ages, but it most often starts during childhood. In the United States, more than 25 million people are known to have asthma and about 7 million of these people are children. About 2 conferences in UK, 1 in USA, 1 in Korea related to asthma will be organized recently.
Market Analysis:
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd Rhinology and Otology Conference
April 25-27, 2016 Dubai, UAE
4th Bacteriology and Infectious Diseases Conference
May 16-18, 2016 San Antonio, USA
2nd Respiratory and Pulmonary Medicine Conference
May 09-10, 2016 Chicago, USA
3rd COPD conference
July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference:
August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences
August 24-26, 2015 West Drayton, London, UK
4th Lung and Respiratory Care Conference
Aug-1-3, 2016 Manchester, UK
4th Immunology Conference
September 28-30, 2015 Houston, Texas, USA
Infectious Diseases and Diagnostic Microbiology Conference
Oct 3-5, 2016 Vancouver, Canada
2nd Flu Conference
November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat centers:
GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on November 22, 2024
